期刊文献+

肾素-血管紧张素-醛固酮系统在慢性心力衰竭中的意义 被引量:2

The changes and signi ficance of renin-angiotensin-aldostcronelactivity in patients with chronic heart failure
下载PDF
导出
摘要 目的探讨慢性心力衰竭(CHF)患者肾素-血管紧张素-醛固酮系统(RAAS)的活性。方法采用放免法测定不同血压CHF患者A组(SBP>13.33kPa)22例、B组(SBP<13.33kPa)22例及健康对照组C组25例的血浆肾素活性(PRA)、血管紧张素Ⅱ(AngⅡ)、醛固酮(ALD)及血清钠水平。结果A组及B组血浆PRA、AngⅡ和ALD均明显高于对照组C组(P<0.01);A组血清钠、血浆PRA、AngⅡ和ALD高于B组(P<0.01);A组血清钠、显著低于B组(P<0.01)。结论CHF患者体内RAAS活性增高,且SBP<13.33kPa者高于SBP>13.33kPa者。 objective To explore therenin-angiotensin-aldosterone system (RAAS) activity of patients with congestive heart failure (CHF).Methods 44 patients were divided into two groups ac cording to their systolic blood pressure (SBP):①patients with SBP<13.33kPa(A,n=22);②patients with SBP>13.33kPa (B,n=22).Normal control group incuded 25 health people(C,n=25). Plasm allevel sofrenin, angiotensin and aldosterone activity (PRA,Ang Ⅱ and ALD) were measured by radio-immunityas say (RIA).Results Plasm alevels of PRA, AnglIand ALD in A and B groups were significantly higher than Thosein control group(P<0.01), especially in Agroup (compared with B group,P<0.01).A group had lower serum sodium, SBP and puls epressure/systo licpressure compared with B group(P<0.01). Conclusion RAAS activity llncrease din the CHF patients,especially in the patients with SBP lower than 13.33kPa.
出处 《中国老年保健医学》 2006年第4期21-22,共2页 Chinese Journal of Geriatric Care
关键词 心力衰竭 血压 肾素-血管紧张素-醛固酮系统 heart failure, blood pressure, renin-angiotensin-aldosterone system
  • 相关文献

参考文献2

二级参考文献19

  • 1金惠铭.病理生理学[M](第5版)[M].北京:人民卫生出版社,2001.26. 被引量:7
  • 2Cosin Aguilar J, et al. Neurohormonal factor in heart failure. Rev Esp Cardiol 1996;49(4):239 被引量:1
  • 3Lee AF, Mac Fadyen R J, Struthers AD. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy : a longitudinal study[ J]. Eur J Heart Fail, 1999,1 (4) :401-406. 被引量:1
  • 4Rouleau JL, Packer M, Moye L, et al. Prognostic value of neurohumoral activation in Patients with an acute myocardial infarction: effect of captopril [J] .J Am Coll Cardiol, 1994,24(3) :583-591. 被引量:1
  • 5Bauer JH,Reams GP.The angiotensin Ⅱ type Ⅰ receptor antagonists, A new class of anti-hypertensive drugs[ J]. Arch Intern Med, 1995,155 (13): 1361-1368. 被引量:1
  • 6Regitz ZV, Neuss M, Warnecke C, et al. Angiotensin receptors organ and subtype specific regulation in cardiovascular diseases by modulation of the rennin-angiotensin system,studies of therate modeland in human myocardium[ J]. Z Cardiol, 1995,84 [ Suppl 4 ]: 61-63. 被引量:1
  • 7Goodfriend TL,Elliott ME,Catt KJ.Drug therapy:angiotensin receptors and their antagonists[J] .N Engl J Med, 1996,334(25):1649-1654. 被引量:1
  • 8Wilke A, Funck R, Rupp H, et al. Effect of the rennin-angiotensin-aldosterone system on the cardiac interstitium in heart failure [J]. Basic Res Cardiol,1996,91[Suppl 2] :79-84. 被引量:1
  • 9Asmar R, Makonna O, Brisac AM, et al. Comparison between the ef fects of angiotensin-converting-enzyme inhibitors and angiotensin Ⅱ antagonists[ J]. Therapie, 1998,53(3) :253-270. 被引量:1
  • 10Weber KT, Villarreal D. Aldosterone and antialosteroe therapy in congestive heart failure[ J]. Am J Cardlol, 1993,71 [ Suppl ]: s3-s1 1. 被引量:1

共引文献20

同被引文献28

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部